Clinical Trial Update: Evaluation of the Safety, Feasibility and Usability of the EPD D700 System in Atrial Flutter Ablation Procedures [NA]

View source ↗

Summary

The trial evaluating the EPD D700 System for atrial flutter ablation has been withdrawn, with no results reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Flutter

Drugs mentioned

• EPD D700 System

Snippet

Sponsor: EPD Solutions, A Philips Company | Conditions: Atrial Flutter | NA | Status: WITHDRAWN